Killing cancer : discovery and selection of new target molecules / editor, Tuula Kallunki
Material type:
- text
- computer
- online resource
- 9783039434411
Item type | Current library | Collection | Status | Barcode | |
---|---|---|---|---|---|
![]() |
Accessible online | Circulation | Available | EB-00308 |
Includes bibliographical references.
Seeking and exploring efficient ways to target cancer
Immunotherapy, inflammation and colorectal cancer
Oncofetal chondroitin sulfate : a putative therapeutic target in adult and pediatric solid tumors
Targeting mTOR and metabolism in cancer : lessons and innovations
Mutations that confer drug-resistance, oncogenicity and intrinsic activity on the ERK MAP kinases - current state of the art
The pyrazolo[3,4-d]pyrimidine derivative, SCO-201, reverses multidrug resistance mediated by ABCG2/BCRP
The vacuolar H+ ATPase α3 subunit negatively regulates migration and invasion of human pancreatic ductal adenocarcinoma cells
Ferlin overview : from membrane to cancer biology
Zinc finger transcription factor MZF1 - a specific regulator of cancer invasion
Targeting the NPL4 adaptor of p97/VCP segregase by disulfiram as an emerging cancer vulnerability evokes replication stress and DNA damage while silencing the ATR pathway
Disruption of the NF-κB/IL-8 signaling axis by sulconazole inhibits human breast cancer stem cell formation
Dexamethasone inhibits spheroid formation of thyroid cancer cells exposed to simulated microgravity
The oncogene AF1Q is associated with WNT and STAT signaling and offers a novel independent prognostic marker in patients with resectable esophageal cancer
Comment on “dexamethasone inhibits spheroid formation of thyroid cancer cells exposed to simulated microgravity”
Science between bioreactors and space research - response to comments by Joseph J. Bevelacqua et al. on “dexamethasone inhibits spheroid formation of thyroid cancer cells exposed to simulated microgravity”
There are no comments on this title.